ACHE and Alzheimer disease: Several alkaloids alter the pathophysiology of AD by functioning as muscarinic receptor agonists, antioxidants, acetylcholinesterase and butyrylcholinesterase inhibitors, α-synuclein aggregation inhibitors, anti-amyloid, and monoamine oxidase (MAO) inhibitors [197].